Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulant Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00039858
What this trial is testing

Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

Who this might be right for
ThrombocytopeniaThrombosis
Encysive Pharmaceuticals 24
Not applicableUnknownNCT06232278
What this trial is testing

Long-term Results of Percutaneous Left Atrial Closure at Brest University Hospital (CLAPOT)

Who this might be right for
Atrial FibrillationCardioembolic StrokeLeft Atrial Appendage Thrombosis+1 more
University Hospital, Brest 120
Not applicableStudy completedNCT03280368
What this trial is testing

Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation

Who this might be right for
Atrial FibrillationMedication AdherenceBlood Coagulation Tests+10 more
Hospitalsenheden Vest 430
Not applicableUnknownNCT04868214
What this trial is testing

Multi-site Study for Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants and Verification of Measurement Precision of Liquid Quality Controls With the Perosphere Technologies' PoC Coagulometer

Who this might be right for
Coagulation
Sciema UG 300
Not applicableLooking for participantsNCT07309848
What this trial is testing

Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs

Who this might be right for
Blood TransfusionHip Fracture SurgeriesGeriatric+6 more
St. Antonius Hospital 374
Large-scale testing (Phase 3)Study completedNCT01674647
What this trial is testing

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion

Who this might be right for
Atrial Fibrillation
Bayer 1,504
Not applicableStudy completedNCT05946863
What this trial is testing

Caudal Block & Hip Fracture Surgery in Anticoagulated Patient

Who this might be right for
Hip FracturesAnticoagulants and Bleeding Disorders
Salem Anaesthesia Pain Clinic 100
Not applicableUnknownNCT04462614
What this trial is testing

Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA

Who this might be right for
Chronic HemolysisVKAAnticoagulants / Administration & Dosage+7 more
CHU de Reims 49
Post-approval studies (Phase 4)Active Not RecruitingNCT04276155
What this trial is testing

Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia

Who this might be right for
Atrial Fibrillation, Myocardial Infarction
Centre Hospitalier de PAU 500
Not applicableUnknownNCT04671160
What this trial is testing

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

Who this might be right for
Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis
Medical University of Gdansk 80
Post-approval studies (Phase 4)Study completedNCT00966290
What this trial is testing

Anticoagulant Clinics and Vitamin K Antagonists

Who this might be right for
Blood Coagulation Disorders
University Hospital, Toulouse 1,006
Post-approval studies (Phase 4)Study completedNCT00689520
What this trial is testing

Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis

Who this might be right for
Venous Thromboembolism
Hospital Universitari de Bellvitge 241
Not applicableUnknownNCT00182117
What this trial is testing

Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population

Who this might be right for
BleedingEnd Stage Renal Disease
Hamilton Health Sciences Corporation 490
Not applicableStudy completedNCT02800941
What this trial is testing

Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Centre Hospitalier Universitaire de Saint Etienne 203
Not applicableUnknownNCT02987062
What this trial is testing

MultiCenter expeRience in AFib Patients Treated With OAC (CRAFT)

Who this might be right for
Atrial Fibrillation
Medical University of Warsaw 2,000
Not applicableLooking for participantsNCT06957366
What this trial is testing

Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

Who this might be right for
Atrial Fibrillation (AF)VTE
McMaster University 920
Large-scale testing (Phase 3)Looking for participantsNCT06878066
What this trial is testing

Thrombolysis in Factor Xa-inhibitors Trial

Who this might be right for
StrokeStroke (in Patients With Atrial Fibrillation)Ischemic Stroke+6 more
Guri Hagberg 300
Post-approval studies (Phase 4)Study completedNCT04437303
What this trial is testing

Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

Who this might be right for
Aortic Valve DiseaseAortic Valve StenosisStroke+4 more
St. Antonius Hospital 858
Not applicableStudy completedNCT07774273
What this trial is testing

Bleeding Risk With Apixaban Versus Rivaroxaban in Acute Pulmonary Embolism

Who this might be right for
Pulmonary Embolism AcuteVenous Thromboembolism (VTE)
Combined military hospital lahore 540
Not applicableStudy completedNCT03006341
What this trial is testing

Validation of Predictors of OAC Initiation Using EMR Data

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 140,187
Next Page